JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB55391

Anti-Ras antibody [4F3]

4

(11 Reviews)

|

(41 Publications)

Mouse Monoclonal RASK antibody. Suitable for Flow Cyt, WB and reacts with Human samples. Cited in 41 publications. Immunogen corresponding to Recombinant Fragment Protein within Human KRAS aa 1-150.

View Alternative Names

KRAS2, RASK2, KRAS, GTPase KRas, K-Ras 2, Ki-Ras, c-K-ras, c-Ki-ras

2 Images
Flow Cytometry - Anti-Ras antibody [4F3] (AB55391)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-Ras antibody [4F3] (AB55391)

Overlay histogram showing HeLa cells stained with ab55391 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab55391, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a slightly decreased signal in HeLa cells fixed with methanol (5 min)/permeabilized with 0.1% PBS-Tween 20 used under the same conditions.

This image was generated using the ascites version of the product.

Western blot - Anti-Ras antibody [4F3] (AB55391)
  • WB

Unknown

Western blot - Anti-Ras antibody [4F3] (AB55391)

cK Ras antibody (ab55391) at 1ug/lane + HeLa cell lysate at 25ug/lane.

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-Ras antibody [4F3] (ab55391)

Predicted band size: 21 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

4F3

Isotype

IgG2a

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

WB, Flow Cyt

applications

Immunogen

Recombinant Fragment Protein within Human KRAS aa 1-150. The exact immunogen used to generate this antibody is proprietary information.

P01116

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg2c-kappa-monoclonal-18c8bc7ad10-isotype-control-ab170191'>ab170191</a> - Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>" } } }

Product details

This product was changed from ascites to tissue culture supernatant on 13th Feb 2019. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
pH: 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Ras protein also known by its alternate names such as KRAS NRAS and HRAS functions as a small GTPase which is a type of enzyme that binds to guanosine triphosphate (GTP) and can switch to an inactive form when it hydrolyzes GTP to GDP. Ras proteins are encoded by genes located in different chromosomes and typically have a molecular weight of about 21 kDa. These proteins are expressed in various tissues throughout the body where they play key roles in cellular signaling.
Biological function summary

Ras proteins are pivotal in regulating cell proliferation differentiation and survival. They are often part of larger protein complexes that facilitate signal transduction across cell membranes. These proteins function as binary molecular switches toggling between active (GTP-bound) and inactive (GDP-bound) states. Mutations in Ras proteins such as NRAS Q61R can lead the protein to assume permanently active conformations disrupting normal cellular signaling processes and contributing to oncogenesis.

Pathways

Ras proteins play significant roles in the MAPK/ERK and PI3K/AKT signaling pathways. Their activation leads to a cascade of phosphorylation events that ultimately regulate gene expression. Within these pathways Ras proteins interact with various molecules including RAF kinases and the PI3K protein further illustrating their complex roles in signal propagation. These pathways control many cellular processes including growth differentiation and survival illustrating how Ras proteins integrate multiple signals to modulate cellular outcomes.

Ras proteins are frequently implicated in various cancers notably pancreatic and colorectal cancers. Mutated forms of Ras such as KRAS G12V drive oncogenesis by promoting uncontrolled cell growth and division. In cancer pathology Ras often interacts with tumor suppressor proteins influencing the disease progression. Targeting Ras-mediated signaling pathways using approaches like pan-Ras inhibitors or chemiluminescence ELISAs represents an ongoing area of therapeutic research aimed at combating Ras-driven malignancies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Ras proteins bind GDP/GTP and possess intrinsic GTPase activity (PubMed : 20949621, PubMed : 39809765). Plays an important role in the regulation of cell proliferation (PubMed : 22711838, PubMed : 23698361). Activates MAPK1/MAPK3 resulting in phosphorylation and ultimately degradation of GJA1 (By similarity). Plays a role in promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (TSGs) in colorectal cancer (CRC) cells in a ZNF304-dependent manner (PubMed : 24623306).
See full target information KRAS

Publications (41)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 25: PubMed39201772

2024

CRISPR/Cas-Mediated Knockdown of PD-L1 and KRAS in Lung Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Summer A Abounar,Nefertiti A El-Nikhely,Kati Turkowski,Rajkumar Savai,Hesham Saeed

RSC advances 13:14685-14697 PubMed37197682

2023

Integrated pipeline for ultrasensitive protein detection in cancer nanomedicine.

Applications

Unspecified application

Species

Unspecified reactive species

Chi-An Cheng,Li-Chiao Chiang,Yu-Syuan Chu

Theranostics 12:7646-7667 PubMed36451861

2022

Janus USPION modular platform (JUMP) for theranostic ultrasound-mediated targeted intratumoral microvascular imaging and DNA/miRNA delivery.

Applications

Unspecified application

Species

Unspecified reactive species

Ragnhild D Whitaker,Julius L Decano,Catherine Gormley,Carl A Beigie,Cari Meisel,Glaiza A Tan,Ann-Marie Moran,Nicholas J Giordano,Yoonjee Park,Peng Huang,Sean Andersson,Donald Gantz,Aaron K Grant,Nelson Ruiz-Opazo,Victoria L M Herrera,Joyce Y Wong

Cancer research 82:3375-3393 PubMed35819261

2022

Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL.

Applications

Unspecified application

Species

Unspecified reactive species

Russell Moser,James Annis,Olga Nikolova,Cliff Whatcott,Kay Gurley,Eduardo Mendez,Kim Moran-Jones,Craig Dorrell,Rosalie C Sears,Calvin Kuo,Haiyong Han,Andrew Biankin,Carla Grandori,Daniel D Von Hoff,Christopher J Kemp

Oncogene 41:2210-2224 PubMed35220407

2022

Targeted siRNA nanocarrier: a platform technology for cancer treatment.

Applications

Unspecified application

Species

Unspecified reactive species

Nicole Bäumer,Jessica Tiemann,Annika Scheller,Theresa Meyer,Lisa Wittmann,Matias Ezequiel Gutierrez Suburu,Lilo Greune,Matthias Peipp,Neele Kellmann,Annika Gumnior,Caroline Brand,Wolfgang Hartmann,Claudia Rossig,Carsten Müller-Tidow,Dario Neri,Cristian A Strassert,Christian Rüter,Petra Dersch,Georg Lenz,H Phillip Koeffler,Wolfgang E Berdel,Sebastian Bäumer

Nature communications 12:4164 PubMed34230493

2021

Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Quentin Van Thillo,Jolien De Bie,Janith A Seneviratne,Sofie Demeyer,Sofia Omari,Anushree Balachandran,Vicki Zhai,Wai L Tam,Bram Sweron,Ellen Geerdens,Olga Gielen,Sarah Provost,Heidi Segers,Nancy Boeckx,Glenn M Marshall,Belamy B Cheung,Kiyotaka Isobe,Itaru Kato,Junko Takita,Timothy G Amos,Ira W Deveson,Hannah McCalmont,Richard B Lock,Ethan P Oxley,Maximilian M Garwood,Ross A Dickins,Anne Uyttebroeck,Daniel R Carter,Jan Cools,Charles E de Bock

The American journal of Chinese medicine 48:651-678 PubMed32349518

2020

Cinobufagin Triggers Defects in Spindle Formation and Cap-Dependent Translation in Liver Cancer Cells by Inhibiting the AURKA-mTOR-eIF4E Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaohan Jin,Jiabao Wang,Shuang Zou,Ruicheng Xu,Jin Cao,Yan Zhang,Jia Guo,Xiaochang Wen,Sanmin Deng,Yupiao Zheng,Yu Zhu,Fengmei Wang,Zhongwei Xu

eLife 8: PubMed31674905

2019

High-throughput, single-particle tracking reveals nested membrane domains that dictate KRas diffusion and trafficking.

Applications

Unspecified application

Species

Unspecified reactive species

Yerim Lee,Carey Phelps,Tao Huang,Barmak Mostofian,Lei Wu,Ying Zhang,Kai Tao,Young Hwan Chang,Philip Js Stork,Joe W Gray,Daniel M Zuckerman,Xiaolin Nan

Nature communications 10:3979 PubMed31484926

2019

The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Cristina Oliveira-Mateos,Anaís Sánchez-Castillo,Marta Soler,Aida Obiols-Guardia,David Piñeyro,Raquel Boque-Sastre,Maria E Calleja-Cervantes,Manuel Castro de Moura,Anna Martínez-Cardús,Teresa Rubio,Joffrey Pelletier,Maria Martínez-Iniesta,David Herrero-Martín,Oscar M Tirado,Antonio Gentilella,Alberto Villanueva,Manel Esteller,Lourdes Farré,Sonia Guil

International journal of nanomedicine 14:6589-6600 PubMed31496700

2019

Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis.

Applications

Unspecified application

Species

Unspecified reactive species

Xinquan Liu,Debadyuti Ghosh
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com